TrialThe international journal of neuropsychopharmacology2022

Evaluation of the Safety, Tolerability, and Pharmacokinetic Profiles of TP0473292 (TS-161), A Prodrug of a Novel Orthosteric mGlu2/3 Receptor Antagonist TP0178894, in Healthy Subjects and Its Antidepressant-Like Effects in Rodents.

Mai Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.